Abstract
This review surveys the basic pharmacology of angiotensin II receptors and their antagonism; reviews the existing clinical experience with losartan, the first approved nonpeptide angiotensin II antagonist; suggests other possible clinical areas for angiotensin II receptor antagonism; and compares angiotensin-converting enzyme inhibition with angiotensin receptor antagonism.
| Original language | English |
|---|---|
| Pages (from-to) | 1005-1030 |
| Number of pages | 26 |
| Journal | Clinical Therapeutics |
| Volume | 17 |
| Issue number | 6 |
| DOIs | |
| State | Published - 1995 |
Fingerprint
Dive into the research topics of 'Angiotensin II receptor antagonism: Losartan-sites and mechanisms of action'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver